The Chemours Company (NYSE:CC) went up by 2.47% from its latest closing price when compared to the 1-year high value of $25.35 and move down -64.93%, while CC stocks collected -12.92% of loss with the last five trading sessions. The Wall Street Journal reported on 05/27/20 that CEOs Call in the Coaches as Covid-19 Tests Their Companies
The Chemours Company (NYSE:CC) Worth an Investment?
The Chemours Company (NYSE: CC) The 36 Months beta value for CC stocks is at 2.37, while of the analysts out of 0 who provided ratings for The Chemours Company stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $14.36 which is -$0.77 below current price. CC currently has a short float of 8.73% and public float of 162.64M with average trading volume of 2.90M shares.
CC Market Performance
CC stocks went down by -12.92% for the week, with the monthly jump of 33.07% and a quarterly performance of 68.16%, while its annual performance rate touched -35.53%. The simple moving average for the period of the last 20 days is 9.02% for CC stocks with the simple moving average of 5.40% for the last 200 days.
Analysts’ Opinion on The Chemours Company (NYSE:CC)
Many brokerage firms have already submitted their reports for CC stocks, with Jefferies repeating the rating for CC shares by setting it to “Hold”. The predicted price for CC socks in the upcoming period according to Jefferies is $67 based on the research report published on March 23, 2020.
CFRA, on the other hand, stated in their research note that they expect to see CC stock at the price of $67. The rating they have provided for CC stocks is “Strong Buy” according to the report published on February 14, 2020.
CFRA gave “ Buy” rating to CC stocks, setting the target price at $67 in the report published on November 6, 2019.
CC Stocks 27.65% Far from 50 Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, The Chemours Company was unable to take a rebound, for now settling with -39.37% of loss for the given period.
The stock volatility was left at 5.73%, however, within the period of a single month, the volatility rate increased by 7.81%, while the shares surge at the distance of +38.59% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +104.66% upper at the present time.
In the course of the last 5 trading sessions, CC went down by -12.92%, which changed the moving average for the period of 200 days to the total of +18.32% of gains for the stock in comparison to the 20-day moving average settled at $14.31. In addition, The Chemours Company saw -15.04% in overturn over the period of a single year with a tendency to cut further losses.
CC Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at The Chemours Company (CC), starting from Newman Mark, who bought 2,500 shares at the price of $11.62 back on May 07. After this action, Rushing now owns 133,344 shares of The Chemours Company, valued at $29,048 with the latest closing price.
Snell E Bryan, the President, Titanium Tech of The Chemours Company, bought 11,000 shares at the value of $10.15 during a trade that took place back on Mar 13, which means that Snell E Bryan is holding 141,891 shares at the value of $111,650 based on the most recent closing price.
CC Stock Fundamentals
The current profitability levels are settled at +7.71 for the present operating margin and +19.06 for gross margin. The net margin for The Chemours Company stands at -0.94. Total capital return value is set at 8.39, while invested capital returns managed to touch -1.05. Equity return holds the value -6.00%, with -0.60% for asset returns.
Based on The Chemours Company (CC), the company’s capital structure generated 648.91 points for debt to equity in total, while total debt to capital is set at the value of 86.65. Total debt to assets is settled at the value of 61.60 with long-term debt to equity ratio rests at 1.95 and long-term debt to capital is 619.88.
The value for Enterprise to Sales is 1.04 with debt to enterprise value settled at 0.69. The receivables turnover for The Chemours Company is 7.20 with the total asset turnover at the value of 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.